GillmanPK. Serotonin syndrome: History and risk. Fundam Clin Pharmacol1998; 12: 482–91.
2.
SternbachH. The serotonin syndrome. Am J Psychiatry1991; 148: 705–13.
3.
WhyteI. Serotonin syndrome complicating treatment of recurrent depression. Current Therapeutics1999; 40: 6–7.
4.
GillmanPK. The serotonin syndrome and its treatment. J Psychopharmacol1999; 13: 100–9.
5.
NisijimaKYoshinoTIshiguroT. Risperidone counteracts lethality in an animal model of the serotonin syndrome. Psychopharmacology (Berl)2000; 150: 9–14.
6.
NisijimaKYoshinoTYuiKKatohS. Potent serotonin (5-HT)(2A) receptor antagonists completely prevent the development of hyperthermia in an animal model of the 5-HT syndrome. Brain Res2001; 890: 23–31.
7.
GraudinsAStearmanAChanB. Treatment of the serotonin syndrome with cyproheptadine. J Emerg Med1998; 16: 615–9.
8.
KapurSZipurskyRBJonesCWilsonAADaSilvaJDHouleS. Cyproheptadine: A potent in vivo serotonin antagonist (letter). Am J Psychiatry1997; 154: 884.
9.
RichelsonESouderT. Binding of antipsychotic drugs to human brain receptors: Focus on newer generation compounds. Life Sci2000; 68: 29–39.
10.
GillmanPK. Successful treatment of serotonin syndrome with chlorpromazine. Med J Aust1996; 165: 345–6.
11.
LejoyeuxMRouillonFAdesJ. Prospective evaluation of the serotonin syndrome in depressed inpatients treated with clomipramine. Acta Psychiatr Scand1993; 88: 369–71.
